Risk-adapted chemotherapy without procarbazine in treatment of children with Hodgkin lymphoma

被引：0
|
作者：
Yi-Jin Gao
Jing-Yan Tang
Ci Pan
Feng-Juan Lu
Hui-Liang Xue
Jing Chen
机构：
[1] Fudan University,Children’s Hospital, Shanghai Medical College
[2] Shanghai Jiao Tong University,Shanghai Children’s Medical Center, School of Medicine
[3] Shanghai Jiao Tong University,Shanghai Children’s Medical Center, School of Medicine
来源：
World Journal of Pediatrics | 2013年 / 9卷
关键词：
chemotherapy; children; Hodgkin lymphoma; outcome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：32 / 35
页数：3
相关论文
共 50 条
  • [1] Risk-adapted chemotherapy without procarbazine in treatment of children with Hodgkin lymphoma
    Gao, Yi-Jin
    Tang, Jing-Yan
    Pan, Ci
    Lu, Feng-Juan
    Xue, Hui-Liang
    Chen, Jing
    [J]. WORLD JOURNAL OF PEDIATRICS, 2013, 9 (01) : 32 - 35
  • [2] Risk-adapted strategies for the treatment of Hodgkin lymphoma
    Keller, Jesse
    Carson, Kenneth R.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2015, 14 (10) : 1519 - 1530
  • [3] Recent results of treatment of early stage Hodgkin lymphoma: risk-adapted approaches
    Straus, David J.
    [J]. LEUKEMIA & LYMPHOMA, 2011, 52 (05) : 738 - 739
  • [4] Risk-adapted therapy for advanced-stage Hodgkin lymphoma
    Spinner, Michael A.
    Advani, Ranjana H.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2018, : 200 - 206
  • [5] Risk-adapted transplant strategies for high-risk Hodgkin lymphoma: are we there?
    Lewalle, Philippe
    Wittnebel, Sebastian
    [J]. CURRENT OPINION IN ONCOLOGY, 2016, 28 (05) : 390 - 397
  • [6] Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy
    Craig Moskowitz
    [J]. Cancer Chemotherapy and Pharmacology, 2002, 49 : 9 - 12
  • [7] FDG PET and risk-adapted therapy in Hodgkin's and non-Hodgkin's lymphoma
    Kasamona, Yvette L.
    Wah, Richard L.
    [J]. CURRENT OPINION IN ONCOLOGY, 2008, 20 (02) : 206 - 219
  • [8] Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphoma
    Osman, A.
    Ali, A. M.
    Ahmed, S.
    [J]. PEDIATRIC BLOOD & CANCER, 2018, 65 : S207 - S208
  • [9] Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy
    Moskowitz, C
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 49 (Suppl 1) : S9 - S12
  • [10] Mantle cell lymphoma: a model for risk-adapted treatment approach
    Kim, Seok Jin
    [J]. BLOOD RESEARCH, 2014, 49 (01) : 1 - 2
12345